Should I Buy BRN? BRN 2026 Analysis

Should You Buy Barnwell Industries Inc (BRN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

1.010

1 Day change

2.23%

52 Week Range

2.280

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: trend and momentum are bearish with no proprietary buy signals to justify an immediate entry.
Price (pre-market ~1.0217) is below the pivot (1.117) and sitting under/near support (S1 1.029), increasing the risk of a breakdown toward S2 (0.975).
Short-term pattern stats suggest limited upside near-term but a materially negative 1-month bias (-8.48%), which is unfavorable for an impatient buyer.
Intellectia signals: No signal on given stock today for both AI Stock Picker (no pre-mkt buy) and SwingMax (no recent entry), removing a key “act now” catalyst.

Technical Analysis

Trend: Bearish structure with SMA_200 > SMA_20 > SMA_5 (downtrend across long/medium/short timeframes).
Momentum: MACD histogram is negative (-0.00763) and expanding lower, indicating weakening momentum.
RSI (6): 38.07 (not deeply oversold), suggesting downside can continue before a strong mean-reversion setup appears.
Levels: Pivot 1.117 is overhead resistance; near-term resistance at 1.205 (R1). Support at 1.029 (S1) is being tested; next support 0.975 (S2). A clean reclaim of 1.117 would be needed to improve the technical picture.
Quant pattern read: Similar-pattern projection shows small expected move next day/week but negative next month (-8.48%), aligning with the bearish setup.

Positive Catalysts

becomes more plausible.

Neutral/Negative Catalysts

- No news in the recent week, so there are no identifiable near-term event-driven catalysts to reverse the downtrend.
- Technical pressure: bearish MAs + deteriorating MACD momentum increases odds of further weakness.
- Similar-pattern outlook flags meaningful 1-month downside (-8.48%).
- Trading trends are neutral (no notable hedge fund/insider accumulation), reducing confidence in a near-term turnaround.
- Gross margin is negative and deteriorated sharply YoY (-1.47, -114.43% YoY), pointing to ongoing core profitability issues.

Financial Performance

Latest quarter: 2025/Q4.
Revenue: 3.002M, down -19.50% YoY (top-line contraction).
Profitability: Still unprofitable but improving—Net Income -2.429M (improved +29% YoY) and EPS -0.24 (improved +26.32% YoY).
Margins: Gross margin negative and worse YoY (-1.47), which is a major red flag for sustainable improvement despite the narrower loss.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data provided, implying no recent visible Wall Street re-rating catalyst in this dataset.
Wall Street pro/con view based on available data: Pros—loss narrowing and potential technical bounce if support holds. Cons—revenue decline, sharply negative gross margin, bearish trend, and lack of fresh catalysts or accumulation signals.

Analyst Rating

Wall Street analysts forecast BRN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRN is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold